<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://sgc.anlis.gob.ar/handle/123456789/4">
    <title>DSpace Community: INEI</title>
    <link>http://sgc.anlis.gob.ar/handle/123456789/4</link>
    <description>INEI</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://sgc.anlis.gob.ar/handle/123456789/2755" />
        <rdf:li rdf:resource="http://sgc.anlis.gob.ar/handle/123456789/2751" />
        <rdf:li rdf:resource="http://sgc.anlis.gob.ar/handle/123456789/2750" />
        <rdf:li rdf:resource="http://sgc.anlis.gob.ar/handle/123456789/2749" />
      </rdf:Seq>
    </items>
    <dc:date>2026-06-10T10:29:17Z</dc:date>
  </channel>
  <item rdf:about="http://sgc.anlis.gob.ar/handle/123456789/2755">
    <title>Impact of Cefiderocol on Klebsiella pneumoniae: A Population-based Longitudinal Analysis of Phenotypic and Genotypic Responses at Subinhibitory and Inhibitory Concentrations</title>
    <link>http://sgc.anlis.gob.ar/handle/123456789/2755</link>
    <description>Title: Impact of Cefiderocol on Klebsiella pneumoniae: A Population-based Longitudinal Analysis of Phenotypic and Genotypic Responses at Subinhibitory and Inhibitory Concentrations
Authors: Traglia, German M; Moheb, Samyar; Akhar, Usman; Quiroga, Cecilia; Tuttobene, Marisel R; Mase, Hamza; Pasteran, Fernando; Rao, Gauri G.; Tolmasky, Marcelo E.; Bonomo, Robert A; Ramirez, Maria Soledad
Abstract: Background: Cefiderocol (FDC) is a siderophore cephalosporin active against carbapenem-resistant Klebsiella pneumoniae (CRKP), but resistance has emerged, often involving iron-uptake pathways and β-lactamases. We investigated how an NDM-producing clinical isolate adapts to FDC under stepwise selective pressure.&#xD;
&#xD;
Methods: A ST147 K. pneumoniae isolate (Kp-1) carrying blaNDM-5 and blaOXA-181, susceptible to FDC but resistant to other agents, was propagated in iron-depleted Mueller-Hinton broth with progressive FDC exposure. Population-based whole-genome sequencing (WGS) tracked mutation dynamics, and RT-qPCR profiled 17 genes related to FDC resistance, iron acquisition, and virulence, comparing the parental population (G0) to the first exposed generation (G1 + FDC).&#xD;
&#xD;
Results: The mean number of mutations detected in generation G1 under FDC exposure was 24.3 ± 12.2, and in generation G2, it increased to 31.7 ± 6.4. Two nonsynonymous substitutions in baeS (V295G and T299P) were recurrently selected, with V295G reaching ≥ 70% frequency in independent lineages, indicating convergent evolution. RT-qPCR revealed downregulation of iron-uptake and porin genes (iroN, cirA, fepA, kfu, ompK35), and upregulation of entB, ompK36, blaNDM-5, and capsule-related genes (wzm, wbbM); baeS/baeR transcript levels were unchanged. Early FDC exposure enhanced biofilm formation without significantly affecting capsule production.&#xD;
&#xD;
Conclusions: Short-term FDC exposure reproducibly selects baeS variants and triggers a transcriptional program reducing siderophore-receptor entry and remodeling the outer membrane. These adaptations-together with increased blaNDM-5 expression and biofilm formation-contribute to reduced FDC susceptibility. The recurrent baeS mutations (V295G/T299P) and decreased cirA/fepA expression may serve as early surveillance markers of FDC adaptation in K. pneumoniae.</description>
    <dc:date>2026-05-12T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://sgc.anlis.gob.ar/handle/123456789/2751">
    <title>Manual de interpretación de resultados para la identificación de levaduras de interés médico por MALDI-TOF</title>
    <link>http://sgc.anlis.gob.ar/handle/123456789/2751</link>
    <description>Title: Manual de interpretación de resultados para la identificación de levaduras de interés médico por MALDI-TOF
Authors: Arias, Barbara; Canteros, Cristina Elena; Gómez, Yanina; Taverna, Constanza Giselle; Vivot, Matias Ezequiel
Abstract: [RESUMEN]: El objetivo de este manual es presentar la validación o verificación de las bases de datos para la identificación de levaduras de importancia clínica utilizando los Equipos comerciales Bruker y VITEK MS. Así como dar recomendaciones para la identificación de levaduras utilizando estos equipos basadas fundamentalmente en los resultados obtenidos de estos procesos de validación y verificación. En algunos casos, donde nuestra evidencia es escasa o ninguna, se incluyó información obtenida de búsquedas bibliográficas.
Description: Fil: Arias, Bárbara. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Ciudad Autónoma de Buenos Aires, Argentina; Fil: Canteros, Cristina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Ciudad Autónoma de Buenos Aires, Argentina; Fil: Gómez, Yanina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Ciudad Autónoma de Buenos Aires, Argentina; Fil: Taverna, Costanza. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Ciudad Autónoma de Buenos Aires, Argentina; Fil: Vivot, Matías. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Ciudad Autónoma de Buenos Aires, Argentina</description>
    <dc:date>2026-04-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://sgc.anlis.gob.ar/handle/123456789/2750">
    <title>Establishment of epidemiological cutoff values for clinically relevant Sporothrix species using CLSI-broth microdilution</title>
    <link>http://sgc.anlis.gob.ar/handle/123456789/2750</link>
    <description>Title: Establishment of epidemiological cutoff values for clinically relevant Sporothrix species using CLSI-broth microdilution
Authors: dos Santos, Amanda R; Bonifaz, Alexandro; Bombassaro, Amanda; Sá Machado, Ana Caroline de; Rodrigues. Anderson; Borman, Andrew M.; Chakrabarti, A; Chowdary, Anuradha; Rediguieri, Bruno; Johnson, E M; Hagen, Ferry; Queiroz-Telles, Flavio; Gonzalez, Gloria M.; Garcia-Effron, Guillermo; Ferreira Gremião, Isabella Dib; Meis, Jacques F; Possato Fernandes Takahas, Juliana; Pereira Borba dos Santos, Luana; Melhem, Marcia C.; Cappellano, Paola; Nogueira Brilhante, Raimunda Sâmia; Pereira, Sandro Antonio; Santos Gonçalvez, Sarah; Kidd, Sarah; Zhang, Sean X.; Rudramurthy, Shivaprakash; Rozental, Sonia; Córdoba, Susana; De Groot, Theun; Liu, Wei; Wiederhold, Nathan P.; Meijer, Eelco F. J.; Lockhart, Shawn R.; Dufresne, Philippe J.
Abstract: Sporotrichosis is a globally distributed subcutaneous mycosis caused mainly&#xD;
by Sporothrix brasiliensis, S. schenckii, and S. globosa. Cat-transmitted sporotrichosis,&#xD;
primarily caused by S. brasiliensis in South America and to a lesser extent by S. schenckii&#xD;
in Southeast Asia, is emerging as a substantial public health concern due to its outbreak&#xD;
potential. Itraconazole is the first-line drug for the treatment of humans and cats, but&#xD;
reduced susceptibility has been reported based on previously proposed epidemiologi&#xD;
cal cut-off values (ECVs). To support resistance surveillance, we aimed to establish the&#xD;
Clinical and Laboratory Standards Institute (CLSI)-endorsed ECVs for these clinically&#xD;
relevant Sporothrix species. A total of 3,504 minimum inhibitory concentration (MIC)&#xD;
values for six antifungal agents (amphotericin B, itraconazole, posaconazole, voricona&#xD;
zole, isavuconazole, and terbinafine) were obtained from 19 international laboratories.&#xD;
Four of seven antifungals met the CLSI M57 guidelines criteria to determine the ECV.&#xD;
Established ECVs for amphotericin B were found to be high, with 8 μg/mL for S.&#xD;
brasiliensis and S. globosa, and 4 μg/mL for S. schenckii. Itraconazole ECVs were 4 μg/mL&#xD;
for S. brasiliensis and S. schenckii. Posaconazole ECVs were 4 μg/mL for all three species&#xD;
(tentative for S. globosa), while the terbinafine ECV for S. brasiliensis was 0.12 μg/mL.&#xD;
Overall, this study establishes validated ECVs for key antifungals against Sporothrix&#xD;
species and identifies a low prevalence of non-wild-type (NWT) isolates (&lt;10% except&#xD;
for S. schenckii and posaconazole), supporting ongoing antifungal resistance monitoring.</description>
    <dc:date>2026-04-06T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://sgc.anlis.gob.ar/handle/123456789/2749">
    <title>Global trends in norovirus genotype distribution among medically attended children with acute gastroenteritis, 2020-2025</title>
    <link>http://sgc.anlis.gob.ar/handle/123456789/2749</link>
    <description>Title: Global trends in norovirus genotype distribution among medically attended children with acute gastroenteritis, 2020-2025
Authors: Cannon, Jennifer L; Bonifacio, Joseph; Fumian, Tulio M; Pabbaraju, Kanti; Pietsch, Corinna; Gonzalez, Mark D; Hossain, Mohammad Enayet; Selvarangan, Rangaraj; Buesa, Javier; Pan, Chao-Yang; Sakon, Naomi; Chang, Jen-Hung; Hewitt, Joanne; Croucher, Dawn; White, Peter A; Mercer, Lewis K; Chuchaona, Watchaporn; Duarte Martinez, Francisco Javier; López Moya, Mariel; Vân Trang,  Nguyên; Hatyoka, Luiza Miyanda; Mans, Janet; Gomes, K. A.; Degiuseppe, Juan Ignacio; Ingunza, Alejandra; Varghese, Tintu; Lay, Margarita K; Santiago, Fabian Gómez; Bartlett, Eddie; Relja, Boris; Barclay, Leslie; Simuyandi, Michelo; Lanata, Claudio F; Rahman, Mustafizur; Poovorawan, Yong; Wu, Fang-Tzy; Pang,  Xiao-Li; Vinjé, Jan
Abstract: Norovirus is a leading cause of acute gastroenteritis, with a broad diversity of genotypes infecting children. NoroSurv is an established global network for norovirus strain surveillance among medically attended children &lt; 5 years of age.</description>
    <dc:date>2026-05-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

